Personal tools

Skip to content. | Skip to navigation

You are here: Home Find A Doctor Donald M. Miller, M.D., Ph.D.
Department of Medicine

Donald M. Miller, M.D., Ph.D.

by Puckett,Paul J last modified Apr 09, 2013 03:33 PM


Donald M. Miller, M.D., Ph.D.






Donald M. Miller, M.D., Ph.D.

  • Professor of Medicine and Pharmacology
  • Chief, Division of Medical Oncology and Hematology
  • Director, James Graham Brown Cancer Center
  • James Graham Brown Foundation Chair
James Graham Brown Cancer Center
530 South Jackson Street
Louisville, KY 40202

502-852-2522 - Academic Office
502-562-4370 - Patient Appointments






ULP Medical Oncology/Hematology

Clinical Expertise

Head and Neck; Medical Oncology; Skin Cancer; Melanoma

 

Board Certifications

  • American Board of Internal Medicine - Internal Medicine


Education and Training

  • Medical School: Duke University

  • Residency: Peter Bent Brigham Hospital, Boston Mass.

  • Fellowship: Harvard University

  • Ph.D.: Duke University


Recent Publications

  • Deng ZB, Zhuang X, Ju S, Xiang X, Mu J, Liu Y, Jiang H, Zhang L, Mobley J, McClain C, Feng W, Grizzle W, Yan J, Miller D, Kronenberg M, Zhang HG. Exosome-like Nanoparticles from Intestinal Mucosal Cells Carry Prostaglandin E2 and Suppress Activation of Liver NKT Cells. J Immunol. 2013 Apr 1;190(7):3579-89. doi: 10.4049/jimmunol.1203170. Epub 2013 Mar 6. PubMed PMID: 23467936.

  • Deng ZB, Zhuang X, Ju S, Xiang X, Mu J, Wang Q, Jiang H, Zhang L, Kronenberg M, Yan J, Miller D, Zhang HG. Intestinal mucus-derived nanoparticle-mediated activation of Wnt/β-catenin signaling plays a role in induction of liver natural killer T cell anergy in mice. Hepatology. 2013 Mar;57(3):1250-61. doi: 10.1002/hep.26086. Epub 2013 Feb 11. PubMed PMID: 22991247.

  • Islam MA, Thomas SD, Sedoris KJ, Slone SP, Alatassi H, Miller DM. Tumor-associated primo vascular system is derived from xenograft, not host. Exp Mol Pathol. 2013 Feb;94(1):84-90. doi: 10.1016/j.yexmp.2012.09.004. Epub 2012 Sep 19. PubMed PMID: 23000426.

  • Miller DM, Thomas SD, Islam A, Muench D, Sedoris K. c-Myc and cancer metabolism. Clin Cancer Res. 2012 Oct 15;18(20):5546-53. doi: 10.1158/1078-0432.CCR-12-0977. PubMed PMID: 23071356; PubMed Central PMCID: PMC3505847.

  • Deng Z, Cheng Z, Xiang X, Yan J, Zhuang X, Liu C, Jiang H, Ju S, Zhang L, Grizzle W, Mobley J, Roman J, Miller D, Zhang HG. Tumor cell cross talk with tumor-associated leukocytes leads to induction of tumor exosomal fibronectin and promotes tumor progression. Am J Pathol. 2012 Jan;180(1):390-8. doi: 10.1016/j.ajpath.2011.09.023. Epub 2011 Nov 7. PubMed PMID: 22067905.

  • Sedoris KC, Thomas SD, Clarkson CR, Muench D, Islam A, Singh R, Miller DM. Genomic c-Myc quadruplex DNA selectively kills leukemia. Mol Cancer Ther. 2012 Jan;11(1):66-76. doi: 10.1158/1535-7163.MCT-11-0515. Epub 2011 Nov 14. PubMed PMID: 22084162.

  • Xiang X, Deng Z, Zhuang X, Ju S, Mu J, Jiang H, Zhang L, Yan J, Miller D, Zhang HG. Grhl2 determines the epithelial phenotype of breast cancers and promotes tumor progression. PLoS One. 2012;7(12):e50781. doi: 10.1371/journal.pone.0050781. Epub 2012 Dec 17. PubMed PMID: 23284647; PubMed Central PMCID: PMC3524252.

  • Telang S, Rasku MA, Clem AL, Carter K, Klarer AC, Badger WR, Milam RA, Rai SN, Pan J, Gragg H, Clem BF, McMasters KM, Miller DM, Chesney J. Phase II trial of the regulatory T cell-depleting agent, denileukin diftitox, in patients with unresectable stage IV melanoma. BMC Cancer. 2011 Dec 13;11:515. doi: 10.1186/1471-2407-11-515. PubMed PMID: 22165955; PubMed Central PMCID: PMC3293785.

  • Natarajan N, Telang S, Miller D, Chesney J. Novel immunotherapeutic agents and small molecule antagonists of signalling kinases for the treatment of metastatic melanoma. Drugs. 2011 Jul 9;71(10):1233-50. doi: 10.2165/11591380-000000000-00000. Review. PubMed PMID: 21770473.

  • Schwartzentruber DJ, Lawson DH, Richards JM, Conry RM, Miller DM, Treisman J, Gailani F, Riley L, Conlon K, Pockaj B, Kendra KL, White RL, Gonzalez R, Kuzel TM, Curti B, Leming PD, Whitman ED, Balkissoon J, Reintgen DS, Kaufman H, Marincola FM, Merino MJ, Rosenberg SA, Choyke P, Vena D, Hwu P. gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma. N Engl J Med. 2011 Jun 2;364(22):2119-27. doi: 10.1056/NEJMoa1012863. PubMed PMID: 21631324; PubMed Central PMCID: PMC3517182.

Document Actions
Personal tools